Results
1 -
6 of
6
(Click
here to explore results)
- Development of potent CPP6–gemcitabine conjugates against human prostate cancer cell line (PC-3). Cristiana Correia, Cristina P. R. Xavier, Diana Duarte, Abigail Ferreira, Sara Moreira, M. Helena Vasconcelos, Nuno Vale
, RSC Med. Chem.
, 2020
, 11
, 268
- Modified nucleoside triphosphates in bacterial research for in vitro and live-cell applications. Adeline Espinasse, Hannah K. Lembke, Angela A. Cao, Erin E. Carlson
, RSC Chem. Biol.
, 2020
, 1
, 333
- Stent containing CD44-targeting polymeric prodrug nanoparticles that release paclitaxel and gemcitabine in a time interval-controlled manner for synergistic human biliary cancer therapy. Dayeon Yun, Hyun-Ouk Kim, Hye Young Son, Yuna Choi, Ilkoo Noh, Jong-Woo Lim, Jihye Kim, Haejin Chun, Geunseon Park, Dong Ki Lee, Sung Il Jang, Eunji Jang, Yong-Min Huh, Seungjoo Haam
, J. Mater. Chem. B
, 2017
, 5
, 6317
- Calcium-based biomaterials for diagnosis, treatment, and theranostics. Chao Qi, Jing Lin, Lian-Hua Fu, Peng Huang
, Chem. Soc. Rev.
, 2018
, 47
, 357
- Pediatric glioblastoma target-specific efficient delivery of gemcitabine across the blood–brain barrier via carbon nitride dots. Piumi Y. Liyanage, Yiqun Zhou, Abdulrahman O. Al-Youbi, Abdulaziz S. Bashammakh, Mohammad S. El-Shahawi, Steven Vanni, Regina M. Graham, Roger M. Leblanc
, Nanoscale
, 2020
, 12
, 7927
- Anti-GPC1-modified mesoporous silica nanoparticles as nanocarriers for combination therapy and targeting of PANC-1 cells. Bianca Martins Estevão, Edson José Comparetti, Nathalia Cristina Rissi, Valtencir Zucolotto
, Mater. Adv.
, 2021
, 2
, 5224